Rarebreed, a portfolio company of Trilantic Capital Partners and Halle Capital Management, has received a significant investment from Revelstoke Capital Partners
Rarebreed
Rarebreed, based in Portland, Maine, is a technology-enabled operator of veterinary practices with the mission to become the employer of choice in veterinary care. Rarebreed prides itself on building trusted, lasting relationships with partner hospitals, with goals to provide top-notch patient care, world-class client service and an unparalleled work experience. Rarebreed continues to build a broad network of practices that value healthcare teams by offering them the tools necessary to grow, improve and reimagine the veterinary experience.
The Deal
Through this partnership with Revelstoke Capital Partners, Rarebreed will continue to expand its footprint and mission of building an integrated healthcare network for pets.
Our Perspective
Roddy O’Neill, Managing Director and Co-Head of Lincoln’s Healthcare Group, commented, “We are grateful and honored for the opportunity to advise Rarebreed on this new partnership with Revelstoke Capital Partners. Rarebreed has built a highly differentiated, technology-enabled platform that is improving the veterinary experience for all stakeholders. We look forward to following the future success of the partnership between Rarebreed, Trilantic, Halle and Revelstoke.”
Meet our Senior Team
My goal is to bring the best of Lincoln to each and every transaction, ensuring the topmost outcomes for our clients.
Roderick O’Neill
Managing Director & Co-head of Healthcare
New York
I am passionate about helping great teams realize exceptional outcomes.
Kyle Stemper
Vice President
ChicagoView More Transactions in Healthcare
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.